As California’s hospitals continue their life-saving work during the COVID-19 pandemic, the hospital associations continue to advocate on behalf of hospitals and their patients, in addition to offering these tools and resources:
The Health Resources and Services Administration (HRSA) recently announced the availability of $1 billion in funding available for health centers appropriated by the American Rescue Plan (ARP). To be eligible, an organization must be an existing health center receiving Health Center Program operational support under sections 330(e), (g), (h), and/or (i) of the Public Health Service Act at the time of application […]
On May 3, the Health Resources and Services Administration announced a new program — the COVID-19 Coverage Assistance Fund (CAF) — that reimburses providers for vaccinations administered to patients enrolled in health plans that either do not cover vaccination fees or cover them with patient cost-sharing.
HRSA Announces Program to Cover COVID-19 Vaccination Costs for Underinsured On May 3, the Health Resources and Services Administration announced a new program — the COVID-19 Coverage Assistance Fund (CAF) — that reimburses providers for vaccinations administered to patients enrolled in health plans that either do not cover vaccination fees or cover them with patient […]
CDPH to Provide 60 Days’ Notice Prior to Ending Waiver for Space and Other Flexibilities On April 28, the California Department of Public Health (CDPH) notified hospitals that it will provide at least 60 days’ notice prior to rescinding any of the provisions of All Facilities Letter 20-26.7, its waiver on space and other flexibilities. […]
A report released in April 2021 details how the COVID-19 pandemic damaged the financial health of California’s more than 400 hospitals in 2020, and forecasts continued fiscal impacts through 2021 and possibly beyond. Even after factoring in federal financial support provided last year through the CARES Act, California hospitals still lost more than $8 billion […]
Administration of Johnson & Johnson Vaccine Resumes On April 23, the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and CDC’s Advisory Committee on Immunization Practices recommended resuming administration of the Johnson & Johnson (aka Janssen or J&J) vaccine.
Due to the surge in COVID-19 cases and the addition of vaccination fields to the COVID-19 tracker, hospitals have asked for additional clarifications on reporting COVID-19 data. To provide this clarification, CHA worked with the California Department of Public Health (CDPH) and U.S. Department of Health and Human Services to update its data reporting guidance and other supporting documents.
The Health Resources and Services Administration will host a webinar on April 13 at 11 a.m. (PT) on the COVID-19 Uninsured Program, which reimburses providers for testing, treating, and administering COVID-19 vaccines to uninsured individuals. More information is available in a frequently asked questions document.
On April 5, the Federal Emergency Management Agency (FEMA) announced the availability of additional funding to reimburse qualifying costs related to safely reopening and operating certain eligible entities (including private nonprofit medical facilities). Items eligible for reimbursement include certain personal protective equipment, cleaning and disinfection, COVID-19 diagnostic testing, screening and temperature scanning, and temporary physical barriers for social distancing. The interim policy includes 100% federal […]